Vir Biotechnology Inc (VIR)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 9,622 | 14,215 | 14,203 | 9,913 | 7,244 | 7,963 | 30,178 | 58,077 | 146,319 | 197,200 | 182,783 | 156,006 | 200,727 | 144,151 | 206,999 | 285,508 | 208,452 | 261,901 | 231,080 | 181,232 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $9,622K ÷ $—K
= —
The payables turnover ratio for Vir Biotechnology Inc is not available for the periods provided in the data. Payables turnover ratio measures how efficiently a company is managing its trade payables by comparing the amount of purchases made on credit to the average accounts payable during a specific period.
The absence of data for payables turnover indicates a lack of information on the company's ability to manage its payables effectively. Without this ratio, it is challenging to evaluate Vir Biotechnology Inc's operational efficiency in paying its suppliers and managing its working capital.
In order to conduct a comprehensive analysis of the company's payables turnover, it would be necessary to obtain the accounts payable and purchases data for the relevant periods and calculate the ratio based on that information. This ratio could provide insights into how efficiently the company is utilizing its credit terms with suppliers and managing its cash flow.
Peer comparison
Dec 31, 2024